Note 6 − Stock-Based Compensation

The following tables summarize information and activity under the plan for the indicated periods.

Options Outstanding
   
Options Vested and Exercisable
 
Range of
Exercise Prices
 
Number
Outstanding
   
Weighted
Average
Remaining
Contractual
Life (Years)
   
Weighted
Average
Exercise
Price
   
Number
Exercisable
   
Weighted
Average
Remaining
Contractual
Life (Years)
   
Weighted
Average
Exercise
Price
 
$ 10.00 - 29.80
   
521,875
     
9.68
   
$
20.78
     
30,750
     
6.43
   
$
28.67
 
$ 47.00 - 138.40 
   
204,093
     
2.96
   
$
88.62
     
204,093
     
2.96
   
$
88.62
 
     
725,968
     
7.79
   
$
39.85
     
234,842
     
3.42
   
$
80.77
 

   
Options
 
   
Number
   
Weighted
Average
Exercise
Price
   
Weighted
Average
Remaining
Contractual
Life (Years)
   
Aggregate
Intrinsic
Value
 
Outstanding, December 31, 2023
   
330,017
   
$
90.63
     
   
$
 
Options granted
   
     
     
     
 
Options exercised
   
     
     
     
 
Options cancelled
   
(72,325
)
   
123.61
     
     
 
Outstanding, December 31, 2024
   
257,692
   
$
81.69
     
4.31
   
$
 
Options granted
   
488,000
     
20.22
     
     
 
Options exercised
   
(625
)
    10.00      
     
 
Options cancelled
   
(19,099
)
   
103.76
     
     
 
Outstanding, December 31, 2025
   
725,968
   
$
39.85
     
7.79
   
$
8
 
Options exercisable, December 31, 2025
   
234,842
   
$
80.77
     
3.42
   
$
8
 

   
RSUs
 
   
Number
   
Weighted
Average
Grant
Date
Fair Value
   
Aggregate
Intrinsic
Value
 
Outstanding, December 31, 2023
   
17,450
   
$
60.81
   
$
 
RSUs granted
   
     
     
 
RSUs vested
   
(7,971
)
   
70.88
     
 
RSUs cancelled
   
(3,376
)
   
58.91
     
 
Outstanding, December 31, 2024
   
6,103
   
$
49.20
   
$
 
RSUs granted
   
     
     
 
RSUs vested
   
(4,020
)
   
59.67
     
 
RSUs cancelled
   
(168
)
   
29.80
     
 
Outstanding, December 31, 2025
   
1,915
   
$
29.80
   
$
 
   
Restricted Stock
 
   
Number
   
Weighted
Average
Grant Date
Fair Value
   
Aggregate
Intrinsic
Value
 
Outstanding, December 31, 2023
   
32,706
   
$
9.11
   
$
 
Restricted stock granted
   
649,000
     
5.91
     
 
Restricted stock vested
   
(12,866
)
   
9.35
     
 
Restricted stock cancelled
   
(36,025
)
   
7.97
     
 
Outstanding, December 31, 2024
   
632,815
   
$
5.95
   
$
1,215
 
Restricted stock granted
   
30,000
     
8.90
     
 
Restricted stock vested
   
(131,459
)
   
5.83
     
 
Restricted stock cancelled
   
(70,599
)
   
6.15
     
 
Outstanding, December 31, 2025
   
460,757
   
$
6.24
   
$
4,807
 

Intrinsic value is calculated as the difference between the per-share market price of our common stock on the last trading day of 2025, which was $16.69 and the grant price of the awards. For awards exercised, the intrinsic value is the difference between market price and the exercise price on the date of exercise.

Stock-based compensation expense is included in operating expense for each period as follows:

Stock-Based Compensation by Type of Award
 
Year Ended
December 31, 2025
   
Year Ended
December 31, 2024
 
Stock options
 
$
637
   
$
1,240
 
RSUs
   
134
     
333
 
Restricted stock
   
1,199
     
329
 
Total stock-based compensation expense
 
$
1,970
   
$
1,902
 

As of December 31, 2025, there was $9,836 of unrecognized stock-based compensation expense; $7,173 related to unvested stock options, $24 related to unvested RSUs, and $2,639 related to unvested restricted stock. These costs are expected to be recognized over a weighted-average period of 3.42 years for options, 0.43 years for RSUs, and 2.75 years for restricted stock.

The fair value of each option grant was estimated on the date of grant using the Black-Scholes option pricing model using the following weighted average assumptions:

   
Year Ended
December 31, 2025
   
Year Ended
December 31, 2024
 
Expected stock price volatility
   
83.26
%
   
%
Risk-free interest rate
   
3.78
%
   
%
Expected life term
   
6.25
     
 
Expected dividends
   
0
%
   
%

Based on the Black-Scholes option pricing model, the weighted average estimated fair value of employee stock options granted was $14.89 per share during 2025. The expected life was determined using the simplified method outlined in ASC 718, “Compensation - Stock Compensation”. Expected volatility of the stock options was based upon historical data and other relevant factors.

Historical Timeline

Fiscal YearFiled
2025Mar 24, 2026Showing above
2024Mar 17, 2025
2023Mar 15, 2024
2022Mar 31, 2023
2018Mar 18, 2019

About Stock Compensation Disclosures

Stock-based compensation disclosures detail the equity awards granted to employees and executives — including stock options, restricted stock units (RSUs), and performance shares — along with the valuation methods and assumptions used to expense them. This section reveals the true cost of talent retention and the alignment between management incentives and shareholder interests.

Key signals: total unrecognized compensation expense and its expected recognition period signal future earnings headwinds from already-granted awards. For stock options, examine Black-Scholes assumptions — expected volatility, risk-free rate, and expected term — as understating any of these reduces reported compensation expense. Compare stock compensation expense as a percentage of revenue against peers to assess dilution cost. Watch vesting schedules for acceleration clauses tied to change-of-control events. Performance-based awards with undemanding targets may indicate weak governance. Add back stock compensation to operating cash flow to calculate a more conservative free cash flow figure.